Theralase (TSXV:TLT) and Ferring Pharmaceuticals will evaluate a new combination therapy for high-risk non-muscle invasive bladder cancer.

Theralase (TSXV:TLT) and Ferring Pharmaceuticals will evaluate a new combination therapy for high-risk non-muscle invasive bladder cancer.

Stem cells use inbuilt map for genetic navigation to repair stroke damage. Explore how brain connections and motor skills are restored.

A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis patients.

Six children with severe congenital heart defects recently received life-saving cardiac surgery led by London-based Professor Victor Tsang, a...

A Tokyo-based startup said transplants of cardiac muscle cells that it engineered from induced pluripotent stem (iPS) cells have helped test subjects...

A Tokyo-based startup said transplants of cardiac muscle cells that it engineered from induced pluripotent stem (iPS) cells have helped test subjects...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise. During tumour excision,...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise. During tumour excision,...

Indian scientists at the Raman Research Institute have developed a non-invasive technique to measure the local density of atoms in quantum systems...